<div id="readability-page-1"><p>In a report released today, Priya Sachdeva from UBS reiterated a Buy rating on NeuroPace, with a price target of <span id="expert-recommendation-target">$18.00</span>.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>According to TipRanks, Sachdeva is a 3-star analyst with an average return of <span>14.0%</span> and a 62.50% success rate.</p> <p>In addition to UBS, NeuroPace also received a Buy from H.C. Wainwright’s Yi Chen in a report issued today. However, on November 25, TR | OpenAI – 4o reiterated a Hold rating on NeuroPace (NASDAQ: NPCE).</p></div>

NPCE

<p>UBS analyst Priya Sachdeva reiterated a Buy rating for NeuroPace with a price target of $18.00. H.C. Wainwright's Yi Chen also issued a Buy rating, while TR | OpenAI – 4o maintained a Hold rating. Sachdeva is noted as a 3-star analyst with a 14.0% average return and a 62.50% success rate.</p>

UBS Keeps Their Buy Rating on NeuroPace (NPCE)